Adverse Cardiovascular Events in Cancer Trials: Missing in Action?

[Display omitted]

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2020-02, Vol.75 (6), p.629-631
Main Authors: Bishopric, Nanette H., Lippman, Marc E.
Format: Article
Language:English
Subjects:
cancer clinical trials
cardio-oncology
cardiovascular disease
reporting of adverse events
U.S. Food and Drug Administration
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 631
container_issue 6
container_start_page 629
container_title Journal of the American College of Cardiology
container_volume 75
creator Bishopric, Nanette H.
Lippman, Marc E.
description [Display omitted]
doi_str_mv 10.1016/j.jacc.2019.12.019
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2355945106</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109719387534</els_id><sourcerecordid>2355945106</sourcerecordid><originalsourceid>FETCH-LOGICAL-e264t-12bd3afe23f174f037934a8ebbe33fb7feba3b77651d1598c83dd3c36f35d8c73</originalsourceid><addsrcrecordid>eNo1kM1KxDAUhYMozjj6Ai5klm5ak96maUWQoYw_MOJmXIc0uZWUTjsmbcG38Vl8MltmXH2L83G55xByzWjIKEvuqrBSWocRZVnIonDECZkzztMAeCZOyZwK4AGjmZiRC-8rSmmSsuyczCCiXIBI5yRfmQGdx2WunLHtoLzua-WW6wGbzi9tMwaNRvf7s3VW1f5--Wa9t83nFK10Z9vm8ZKclWOEV0cuyMfTepu_BJv359d8tQkwSuIuYFFhQJUYQclEXFIQGcQqxaJAgLIQJRYKCiESzgzjWapTMAY0JCVwk2oBC3J7uLt37VePvpM76zXWtWqw7b2MgPMs5owmo3pzVPtih0bund0p9y3_i4_Cw0HA8eHBopNeWxybGutQd9K0VjIqp51lJaed5bSzZJEcAX-Rh3AN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2355945106</pqid></control><display><type>article</type><title>Adverse Cardiovascular Events in Cancer Trials: Missing in Action?</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Bishopric, Nanette H. ; Lippman, Marc E.</creator><creatorcontrib>Bishopric, Nanette H. ; Lippman, Marc E.</creatorcontrib><description>[Display omitted]</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2019.12.019</identifier><identifier>PMID: 32057378</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>cancer clinical trials ; cardio-oncology ; cardiovascular disease ; reporting of adverse events ; U.S. Food and Drug Administration</subject><ispartof>Journal of the American College of Cardiology, 2020-02, Vol.75 (6), p.629-631</ispartof><rights>2020 American College of Cardiology Foundation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32057378$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bishopric, Nanette H.</creatorcontrib><creatorcontrib>Lippman, Marc E.</creatorcontrib><title>Adverse Cardiovascular Events in Cancer Trials: Missing in Action?</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>[Display omitted]</description><subject>cancer clinical trials</subject><subject>cardio-oncology</subject><subject>cardiovascular disease</subject><subject>reporting of adverse events</subject><subject>U.S. Food and Drug Administration</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo1kM1KxDAUhYMozjj6Ai5klm5ak96maUWQoYw_MOJmXIc0uZWUTjsmbcG38Vl8MltmXH2L83G55xByzWjIKEvuqrBSWocRZVnIonDECZkzztMAeCZOyZwK4AGjmZiRC-8rSmmSsuyczCCiXIBI5yRfmQGdx2WunLHtoLzua-WW6wGbzi9tMwaNRvf7s3VW1f5--Wa9t83nFK10Z9vm8ZKclWOEV0cuyMfTepu_BJv359d8tQkwSuIuYFFhQJUYQclEXFIQGcQqxaJAgLIQJRYKCiESzgzjWapTMAY0JCVwk2oBC3J7uLt37VePvpM76zXWtWqw7b2MgPMs5owmo3pzVPtih0bund0p9y3_i4_Cw0HA8eHBopNeWxybGutQd9K0VjIqp51lJaed5bSzZJEcAX-Rh3AN</recordid><startdate>20200218</startdate><enddate>20200218</enddate><creator>Bishopric, Nanette H.</creator><creator>Lippman, Marc E.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20200218</creationdate><title>Adverse Cardiovascular Events in Cancer Trials: Missing in Action?</title><author>Bishopric, Nanette H. ; Lippman, Marc E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e264t-12bd3afe23f174f037934a8ebbe33fb7feba3b77651d1598c83dd3c36f35d8c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>cancer clinical trials</topic><topic>cardio-oncology</topic><topic>cardiovascular disease</topic><topic>reporting of adverse events</topic><topic>U.S. Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bishopric, Nanette H.</creatorcontrib><creatorcontrib>Lippman, Marc E.</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bishopric, Nanette H.</au><au>Lippman, Marc E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adverse Cardiovascular Events in Cancer Trials: Missing in Action?</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2020-02-18</date><risdate>2020</risdate><volume>75</volume><issue>6</issue><spage>629</spage><epage>631</epage><pages>629-631</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32057378</pmid><doi>10.1016/j.jacc.2019.12.019</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2020-02, Vol.75 (6), p.629-631
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_2355945106
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects cancer clinical trials
cardio-oncology
cardiovascular disease
reporting of adverse events
U.S. Food and Drug Administration
title Adverse Cardiovascular Events in Cancer Trials: Missing in Action?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-31T23%3A57%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adverse%20Cardiovascular%20Events%20in%20Cancer%C2%A0Trials:%20Missing%20in%20Action?&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Bishopric,%20Nanette%20H.&rft.date=2020-02-18&rft.volume=75&rft.issue=6&rft.spage=629&rft.epage=631&rft.pages=629-631&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2019.12.019&rft_dat=%3Cproquest_pubme%3E2355945106%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e264t-12bd3afe23f174f037934a8ebbe33fb7feba3b77651d1598c83dd3c36f35d8c73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2355945106&rft_id=info:pmid/32057378&rfr_iscdi=true